共 100 条
[1]
Veldeman M(2016)Delayed cerebral ischaemia prevention and treatment after aneurysmal subarachnoid haemorrhage: a systematic review Br J Anaesth. 117 17-40
[2]
Höllig A(2015)Vasospasm: my first 25 years-what worked? what didn't? what next? Acta Neurochir Suppl 120 1-10
[3]
Clusmann H(2017)Cytochrome P450 eicosanoids in cerebrovascular function and disease Pharmacol Ther. 179 31-46
[4]
Stevanovic A(2019)Humble beginnings with big goals: small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders Prog Neurobiol. 172 23-39
[5]
Rossaint R(2017)Functional screening for G protein-coupled receptor targets of 14,15-epoxyeicosatrienoic acid Prostaglandins Other Lipid Mediat. 132 31-40
[6]
Coburn M(1996)Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes Stroke. 27 971-9
[7]
Loch MR(2010)Epoxyeicosanoid signaling in CNS function and disease Prostaglandins Other Lipid Mediat. 91 68-84
[8]
Davis CM(2015)Soluble epoxide hydrolase in hydrocephalus, cerebral edema, and vascular inflammation after subarachnoid hemorrhage Stroke. 46 1916-22
[9]
Liu X(2007)Soluble epoxide hydrolase: a novel therapeutic target in stroke J Cereb Blood Flow Metab. 27 1931-40
[10]
Alkayed NJ(2008)Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia Stroke. 39 2073-8